Recently added

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry

Cortellini, Alessio; Mazzocca, Alessandro; Orlando, Sarah; Romandini, Davide; Valverde Morales, Claudia Maria; Eremiev, Simeón; Vincenzi, Bruno; Aguilar-Company, Juan; Ruiz- Camps, Isabel (SAGE Publications, 2024-01-18)

Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy

Iraola, Josu; O'Reilly, Maeve; Menne, Tobias; Barba, Pere; Kwon, Mi; Abrisqueta, Pau; IACOBONI, GLORIA; Navarro Garces, Victor (Wiley, 2024-05-21)

Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study

VALABREGA, Giorgio; Hamilton, Erika; Sehouli, Jalid; Fariñas-Madrid, Lorena; Makker, Vicky; Pérez-Fidalgo, J. Alejandro; Van Gorp, Toon (Elsevier, 2024-06-03)

A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer

Ahn, Myung-Ju; Ramalingam, Suresh; Tsao, Anne; Riely, Gregory; Smit, Egbert; FELIP, ENRIQUETA (Future Medicine, 2024)

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

Cabrero de las Heras, sara; Hernández-Yagüe, Xavier; González Valencia, Andrea; Losa, Fernando; Soler Gonzalez, Gemma; Bugès Sanchez, Cristina; Baraibar, Iosune (Elsevier, 2024-06-07)

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry

Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy

Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study

A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry ﻿

Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy ﻿

Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study ﻿

A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer ﻿

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment ﻿

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry

Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy

Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study

A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment